PWM
MRK icon

Proathlete Wealth Management’s Merck MRK Stock Holding History

Proathlete Wealth Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$123K Hold
956
– – 0.03% 89
2026
Q1 		$115K Hold
956
– – 0.03% 87
2025
Q4 		$101K Hold
956
– – 0.03% 98
2025
Q3 		$80.3K Sell
956
-11
-1% -$906 0.02% 104
2025
Q2 		$76.6K Buy
967
+11
+1% +$874 0.02% 103
2025
Q1 		$85.9K Buy
+956
New +$89.3K 0.03% 97

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Proathlete Wealth Management's MRK Position: Q2 2026 in Review

Proathlete Wealth Management held its Merck (MRK) position steady in Q2 2026 at 956 shares worth $123K. The position accounts for 0.03% of the portfolio, ranked #89.

Proathlete Wealth Management first reported a position in MRK in Q1 2025 and has held it in 6 quarters since. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Proathlete Wealth Management held 956 shares of Merck worth $123K as of Q2 2026.
  • Proathlete Wealth Management left its Merck share count unchanged in Q2 2026.
  • Merck made up 0.03% of Proathlete Wealth Management's portfolio in Q2 2026, its #89 holding.
  • Proathlete Wealth Management first reported a position in Merck in Q1 2025 and has held it in 6 quarters since.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Proathlete Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.